Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
Stéphanie Bibert(University of Lausanne), Frédéric Lamoth(Czech Academy of Sciences, Institute of Microbiology), Thomas Brahier(University Hospital of Lausanne), Lauro Damonti(University Hospital of Bern), Nathalie Rufer(Swiss Red Cross), Jean‐Luc Pagani(University of Lausanne), Pierre–Yves Bochud(University of Lausanne), João Lourenço(SIB Swiss Institute of Bioinformatics), Oriol Manuel(University Hospital of Lausanne), Matthaios Papadimitriou‐Olivgeris(University Hospital of Lausanne), Jonathan Tschopp(University of Lausanne), Nicolas Guex(University of Lausanne), Fabio Candotti(Institute of Immunology), Robin Liechti(SIB Swiss Institute of Bioinformatics), Mathieu Quinodoz(University of Leicester), Lou Götz(SIB Swiss Institute of Bioinformatics), Mauro Delorenzi(SIB Swiss Institute of Bioinformatics), Cathy Voide(Hôpital du Valais), Noémie Boillat‐Blanco(University of Lausanne), Mauro Oddo(IMT School for Advanced Studies Lucca), Véronique Erard(Réseau Fribourgeois de Santé Mentale), Olivier Hügli(University of Lausanne), Carlo Rivolta(University of Lausanne), Péter Vollenweider(University of Lausanne)
Cited by 45
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k